Tagged: 

  • Deleted User

    Deleted User
    February 13, 2019 at 2:51 pm

    Hi Norm,

    This is very interesting, especially the included link that discusses in detail.  Does ‘disease modifier ‘indicate cure or stop progression? I am happy to see a botanical extract as a disease modifier in clinical trials 2A.  Do you know how many trial levels are required?  I see the MJFF Inosine is in stage 3 and that is also a disease modifier.

     

    Have you heard of https://www.zhittyaregenerativemedicine.com/

  • Deleted User

    Deleted User
    February 16, 2019 at 12:55 pm

    Thank you Norm for sharing this.   I think the link in that article: http://prag.site/education/therapies-in-development/

    is especially interesting..

Log in to reply.